Nitrite formulations and their use as nitric oxide prodrugs

Abstract

CROSS-REFERENCE TO RELATED APPLICATIONS This application is a continuation of U.S. patent application Ser. No. 18/618,144 filed on Mar. 27, 2024, which is a continuation of U.S. patent application Ser. No. 18/449,273 filed on Aug. 14, 2023, which is a continuation of U.S. patent application Ser.